Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Non-Myeloablative Allogeneic PBSC Transplant for HPV-Associated Cervical/Vaginal Cancer
NCT00005941Phase 2Completed
- Sponsor
- Fred Hutchinson Cancer Center
- Start
- Nov 1999
- Primary completion
- Jun 2005
- Modality
- Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of therapeutic allogeneic lymphocytes in Cervical Cancer (CC), vaginal cancer, sponsored by Fred Hutchinson Cancer Center. Started Nov 1999; status: completed.
02
Drugs
therapeutic allogeneic lymphocytes
03
Conditions
Cervical Cancer (CC)vaginal cancer
Beyond the preview
Go deeper on NCT00005941.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00005941.